Target intelligence / Profile preview

Wnt family member 9A (WNT9A)

Target
WNT9A
Molecular classification
Secreted glycoprotein, Ligand (for Frizzled family receptors), Signaling protein, Other (WNT family)
01

Overview

Wnt family member 9A (WNT9A), previously known as WNT14, is a secreted signaling glycoprotein and a member of the Wnt family, which consists of proteins involved in crucial developmental and homeostatic processes. WNT9A binds to Frizzled-family G protein–coupled receptors on the cell surface to activate the canonical Wnt/β-catenin signaling pathway, regulating gene expression patterns involved in cell fate, proliferation, and differentiation. It is essential for normal progression of embryonic bone and joint development, particularly in chondrocyte maturation and synovial joint formation. WNT9A is expressed in both normal and cancerous tissues, and its dysregulation has been associated with developmental disorders, fibrosis, and cancer.

Other names
Protein Wnt-9aWNT14Protein Wnt-14wingless-type MMTV integration site family, member 9Awingless-type MMTV integration site family, member 14
02

Mechanism of action

Inhibition or modulation of Wnt ligand–receptor interaction (for Wnt pathway inhibitors, not WNT9A-specific); Blockade of Wnt/β-catenin signaling cascade (general for Wnt pathway, e.g., by targeting Porcupine [PORCN], Frizzled, or other Wnt pathway elements)

03

Biological functions

Signal transduction (via canonical Wnt/β-catenin pathway)Regulation of cell fate and patterning during embryogenesisPromotion of chondrocyte maturation and bone developmentJoint formation and maintenanceInduction of cellular senescence and fibroblast activation (e.g., renal fibrosis)Cell proliferation and differentiation
04

Disease associations

Cancer (e.g., involvement in gastric cancer)Fibrosis (e.g., renal fibrosis)Congenital malformations (e.g., proximal symphalangism, Müllerian aplasia)Potential roles in other developmental and proliferative disorders
05

Safety considerations

Broad tissue effects due to key roles in development and homeostasis for Wnt signalingPotential for disruption of organogenesis, bone development, or tissue integrity if targetedPossible induction of tumorigenesis or unwanted tissue fibrosis from modulation

Beyond the preview

Go deeper on Wnt family member 9A (WNT9A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wnt family member 9A (WNT9A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call